<ul><li>Cancer is the second leading cause of death in the U.S., and its economic burden is approximately 1.8% of GDP.</li><li>Dr. Jessica Ohemeng-Dapaah works on early cancer detection and reducing financial burdens on patients and healthcare systems.</li><li>CAR T-cell therapy shows potential in revolutionizing cancer treatment and bridging socioeconomic barriers in accessing treatment.</li><li>Companies can offset the financial burden of cancer by encouraging timely and routine screening and supporting preventative treatment.</li></ul>

Dr. Jessica Ohemeng-Dapaah Sheds Lights on the Economic Burden of Cancer on the U.S. Economy and Businesses

Discover more